Pacira BioSciences, Inc. PCRX Balance Sheet Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| $158.55M-42.7% | $276.77M+80.5% | $153.3M+47.2% | $104.14M-82.2% | ||
| $79.88M-61.6% | $207.84M+65.9% | $125.28M-32.1% | $184.51M+160% | ||
| $124.07M+9.5% | $113.3M+7.3% | $105.56M+7.3% | $98.4M+2.2% | ||
| $152.86M+22.0% | $125.28M+20.1% | $104.35M+8.6% | $96.06M-2.5% | ||
| $547.97M-26.5% | $745.13M+46.1% | $509.99M+2.3% | $498.33M-42.5% | ||
| $140.69M-15.8% | $167.17M-3.9% | $173.93M-5.2% | $183.51M-2.6% | ||
| $20.21M— | $0-100% | $163.24M0.0% | $163.24M+12.4% | ||
| $333.82M-21.6% | $425.97M-11.9% | $483.26M-10.6% | $540.55M-13.4% | ||
| $1.26B-18.6% | $1.55B-1.3% | $1.57B-6.4% | $1.68B-19.0% | ||
| $15.15M-20.8% | $19.13M+21.9% | $15.7M+3.1% | $15.22M+44.4% | ||
| $120.59M-61.1% | $309.92M+218% | $97.38M-34.1% | $147.77M-71.6% | ||
| $372.19M+257% | $104.21M-9.5% | $115.2M-54.1% | $251.06M-25.1% | ||
| $571.81M-26.2% | $775.17M+10.1% | $704.26M-22.3% | $906.19M-32.6% | ||
| 250M+531,815% | 47K+2.2% | 46K0.0% | 46K+2.2% | ||
| -$199.32M+3.4% | -$206.36M-93.2% | -$106.8M+28.2% | -$148.75M+29.8% | ||
| $693.11M-11.0% | $778.35M-10.5% | $870.13M+12.3% | $775.01M+6.1% | ||
| $1.26B-18.6% | $1.55B-1.3% | $1.57B-6.4% | $1.68B-19.0% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Pacira BioSciences, Inc.'s total assets?
- Pacira BioSciences, Inc. (PCRX) holds $1.2B in total assets, down 23.8% year over year.
- How much debt does Pacira BioSciences, Inc. have?
- Pacira BioSciences, Inc. carries $411.2M in total debt against $653.9M of shareholders' equity, a debt-to-equity ratio of 0.63.
- How much cash does Pacira BioSciences, Inc. have?
- Pacira BioSciences, Inc. holds $144.3M in cash and equivalents.
- Can Pacira BioSciences, Inc. cover its short-term obligations?
- Its current ratio is 4.73 — current assets exceed current liabilities.
- Where does Pacira BioSciences, Inc.'s balance sheet data come from?
- Every line is extracted from Pacira BioSciences, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
